☰

cached image

Eric J. Stanbridge - Publications

Affiliations: 
University of California, Irvine, Irvine, CA 
Area:
Cell Biology, Molecular Biology, Biochemistry
Website:
https://www.faculty.uci.edu/profile.cfm?faculty_id=2389
Tree Info Similar researchers PubMed Report error

197/310 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Abd-Aziz N, Stanbridge E, Shafee N. Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53. The Journal of General Virology. PMID 27902314 DOI: 10.1099/Jgv.0.000623  0.339
2015 Abd-Aziz N, Stanbridge EJ, Shafee N. Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation. Oncology Letters. 10: 2192-2196. PMID 26622817 DOI: 10.3892/Ol.2015.3545  0.304
2014 Cheng Y, Ho RL, Chan KC, Kan R, Tung E, Lung HL, Yau WL, Cheung AK, Ko JM, Zhang ZF, Luo DZ, Feng ZB, Chen S, Guan XY, Kwong D, ... Stanbridge EJ, et al. Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma. Oncogene. PMID 25347745 DOI: 10.1038/Onc.2014.353  0.424
2013 Ch'ng WC, Stanbridge EJ, Yusoff K, Shafee N. The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 33: 346-54. PMID 23506478 DOI: 10.1089/Jir.2012.0095  0.354
2012 Chen H, Ko JM, Wong VC, Hyytiainen M, Keski-Oja J, Chua D, Nicholls JM, Cheung FM, Lee AW, Kwong DL, Chiu PM, Zabarovsky ER, Tsao SW, Tao Q, Kan R, ... ... Stanbridge EJ, et al. LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. Cancer Letters. 325: 89-98. PMID 22743615 DOI: 10.1016/J.Canlet.2012.06.005  0.405
2012 Huang Z, Cheng Y, Chiu PM, Cheung FM, Nicholls JM, Kwong DL, Lee AW, Zabarovsky ER, Stanbridge EJ, Lung HL, Lung ML. Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties. Oncogene. 31: 3709-20. PMID 22158051 DOI: 10.1038/Onc.2011.529  0.36
2012 Lung HL, Cheung AK, Ko JM, Cheng Y, Stanbridge EJ, Lung ML. Deciphering the molecular genetic basis of NPC through functional approaches. Seminars in Cancer Biology. 22: 87-95. PMID 22154888 DOI: 10.1016/J.Semcancer.2011.11.002  0.356
2012 Lo PH, Ko JM, Yu ZY, Law S, Wang LD, Li JL, Srivastava G, Tsao SW, Stanbridge EJ, Lung ML. The LIM domain protein, CRIP2, promotes apoptosis in esophageal squamous cell carcinoma. Cancer Letters. 316: 39-45. PMID 22154084 DOI: 10.1016/J.Canlet.2011.10.020  0.351
2012 Law EW, Cheung AK, Kashuba VI, Pavlova TV, Zabarovsky ER, Lung HL, Cheng Y, Chua D, Lai-Wan Kwong D, Tsao SW, Sasaki T, Stanbridge EJ, Lung ML. Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma. Oncogene. 31: 728-38. PMID 21743496 DOI: 10.1038/Onc.2011.272  0.409
2012 Wong VCL, Chen H, Ko JMY, Chan KW, Chan YP, Law S, Chua D, Kwong DLW, Lung HL, Srivastava G, Tang JCO, Tsao SW, Zabarovsky ER, Stanbridge EJ, Lung ML. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype International Journal of Cancer. 130: 83-95. PMID 21387288 DOI: 10.1002/Ijc.25970  0.41
2012 Cheung AK, Lung HL, Ko JM, Ip JC, Zabarovsky E, Stanbridge EJ, Lung ML. Abstract 4002: Functional investigation and identification of dephosphorylation targets of tumor-suppressive protein tyrosine phosphatase, PTPRG Cancer Research. 72: 4002-4002. DOI: 10.1158/1538-7445.Am2012-4002  0.33
2011 Cheung AKL, Ko JMY, Lung HL, Chan KW, Stanbridge EJ, Zabarovsky E, Tokino T, Kashima L, Suzuki T, Kwong DLW, Chua D, Tsao SW, Lung ML. Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-κB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis Proceedings of the National Academy of Sciences of the United States of America. 108: 8390-8395. PMID 21540330 DOI: 10.1073/Pnas.1101747108  0.417
2011 Wong VCL, Ko JMY, Qi RZ, Li PJ, Wang LD, Li JL, Chan YP, Chan KW, Stanbridge EJ, Lung ML. Abrogated expression of DEC1 during oesophageal squamous cell carcinoma progression is age- and family history-related and significantly associated with lymph node metastasis British Journal of Cancer. 104: 841-849. PMID 21326238 DOI: 10.1038/Bjc.2011.25  0.305
2011 Chan KC, Ko JM, Lung HL, Sedlacek R, Zhang ZF, Luo DZ, Feng ZB, Chen S, Chen H, Chan KW, Tsao SW, Chua DT, Zabarovsky ER, Stanbridge EJ, Lung ML. Catalytic activity of Matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 129: 1826-37. PMID 21165953 DOI: 10.1002/Ijc.25855  0.321
2011 Chan SH, Yee Ko JM, Chan KW, Chan YP, Tao Q, Hyytiainen M, Keski-Oja J, Law S, Srivastava G, Tang J, Tsao SW, Chen H, Stanbridge EJ, Lung ML. The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome. International Journal of Cancer. Journal International Du Cancer. 129: 565-73. PMID 20878956 DOI: 10.1002/Ijc.25698  0.459
2010 Cao JN, Shafee N, Vickery L, Kaluz S, Ru N, Stanbridge EJ. Mitogen-activated protein/extracellular signal-regulated kinase kinase 1act/tubulin interaction is an important determinant of mitotic stability in cultured HT1080 human fibrosarcoma cells. Cancer Research. 70: 6004-14. PMID 20570892 DOI: 10.1158/0008-5472.Can-09-4490  0.351
2010 Lo PH, Lung HL, Cheung AK, Apte SS, Chan KW, Kwong FM, Ko JM, Cheng Y, Law S, Srivastava G, Zabarovsky ER, Tsao SW, Tang JC, Stanbridge EJ, Lung ML. Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer Research. 70: 5567-76. PMID 20551050 DOI: 10.1158/0008-5472.Can-09-4510  0.405
2010 Masuda M, Maruyama T, Ohta T, Ito A, Hayashi T, Tsukasaki K, Kamihira S, Yamaoka S, Hoshino H, Yoshida T, Watanabe T, Stanbridge EJ, Murakami Y. CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells. The Journal of Biological Chemistry. 285: 15511-22. PMID 20215110 DOI: 10.1074/Jbc.M109.076653  0.364
2010 Lung HL, Cheung AK, Cheng Y, Kwong FM, Lo PH, Law EW, Chua D, Zabarovsky ER, Wang N, Tsao SW, Stanbridge EJ, Lung ML. Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 127: 304-12. PMID 19921696 DOI: 10.1002/Ijc.25047  0.417
2010 Roslan N, Stanbridge EJ, Yusoff K, Shafee N. Abstract A49: Induction of cell-cycle arrest and apoptosis in MCF7 cancer cells by Newcastle disease virus is associated with upregulation of p21cip and p27kip Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcmusa10-A49  0.34
2009 Cheung AK, Lung HL, Ko JM, Cheng Y, Stanbridge EJ, Zabarovsky ER, Nicholls JM, Chua D, Tsao SW, Guan XY, Lung ML. Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 14478-83. PMID 19667180 DOI: 10.1073/Pnas.0900198106  0.448
2009 Hoebeeck J, De Wilde B, Michels E, Combaret V, Yigit N, De Smet E, Van Roy N, Stanbridge E, Ru N, Laureys G, De Paepe A, Speleman F, Vandesompele J. Chromosome 3p microsatellite allelotyping in neuroblastoma: a report on the technical hurdles. Cancer Investigation. 27: 857-68. PMID 19544108 DOI: 10.1080/07357900902769731  0.429
2009 Shafee N, Kaluz S, Ru N, Stanbridge EJ. PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines. Cancer Letters. 282: 109-15. PMID 19342157 DOI: 10.1016/J.Canlet.2009.03.004  0.387
2009 Liao SY, Lerman MI, Stanbridge EJ. Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development. Bmc Developmental Biology. 9: 22. PMID 19291313 DOI: 10.1186/1471-213X-9-22  0.329
2008 Cheung AK, Lung HL, Hung SC, Law EW, Cheng Y, Yau WL, Bangarusamy DK, Miller LD, Liu ET, Shao JY, Kou CW, Chua D, Zabarovsky ER, Tsao SW, Stanbridge EJ, et al. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. Cancer Research. 68: 8137-45. PMID 18829573 DOI: 10.1158/0008-5472.Can-08-0904  0.464
2008 Veena MS, Lee G, Keppler D, Mendonca MS, Redpath JL, Stanbridge EJ, Wilczynski SP, Srivatsan ES. Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer. Genes, Chromosomes & Cancer. 47: 740-54. PMID 18506750 DOI: 10.1002/Gcc.20576  0.372
2008 Shafee N, Smith CR, Wei S, Kim Y, Mills GB, Hortobagyi GN, Stanbridge EJ, Lee EY. Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Cancer Research. 68: 3243-50. PMID 18451150 DOI: 10.1158/0008-5472.Can-07-5480  0.379
2008 Lung HL, Lo PH, Xie D, Apte SS, Cheung AK, Cheng Y, Law EW, Chua D, Zeng YX, Tsao SW, Stanbridge EJ, Lung ML. Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 123: 401-8. PMID 18449890 DOI: 10.1002/Ijc.23528  0.445
2008 Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, Kwong FM, Miller LD, Liu ET, Yang LC, Lo PH, Stanbridge EJ, Tang JC, Srivastava G, Tsao SW, et al. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Molecular Cancer Research : McR. 6: 592-603. PMID 18403638 DOI: 10.1158/1541-7786.Mcr-07-0154  0.464
2008 Lung HL, Lo CC, Wong CC, Cheung AK, Cheong KF, Wong N, Kwong FM, Chan KC, Law EW, Tsao SW, Chua D, Sham JS, Cheng Y, Stanbridge EJ, Robertson GP, et al. Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 122: 1288-96. PMID 18027848 DOI: 10.1002/Ijc.23259  0.419
2008 Cho D, Signoretti S, Dabora S, Regan M, Seeley A, Mariotti M, Youmans A, Polivy A, Mandato L, McDermott D, Stanbridge E, Atkins M. Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma. Clinical Genitourinary Cancer. 5: 379-85. PMID 17956710 DOI: 10.3816/Cgc.2007.N.020  0.306
2007 Cengel KA, Voong KR, Chandrasekaran S, Maggiorella L, Brunner TB, Stanbridge E, Kao GD, McKenna WG, Bernhard EJ. Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells. Neoplasia (New York, N.Y.). 9: 341-8. PMID 17460778 DOI: 10.1593/Neo.06823  0.308
2007 Kost-Alimova M, Darai-Ramqvist E, Yau WL, Sandlund A, Fedorova L, Yang Y, Kholodnyuk I, Cheng Y, Lung ML, Stanbridge E, Klein G, Imreh S. Mandatory chromosomal segment balance in aneuploid tumor cells Bmc Cancer. 7. PMID 17257397 DOI: 10.1186/1471-2407-7-21  0.438
2007 Lo PH, Leung AC, Kwok CY, Cheung WS, Ko JM, Yang LC, Law S, Wang LD, Li J, Stanbridge EJ, Srivastava G, Tang JC, Tsao SW, Lung ML. Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene. 26: 148-57. PMID 16799631 DOI: 10.1038/Sj.Onc.1209767  0.447
2006 Lung HL, Cheung AK, Xie D, Cheng Y, Kwong FM, Murakami Y, Guan XY, Sham JS, Chua D, Protopopov AI, Zabarovsky ER, Tsao SW, Stanbridge EJ, Lung ML. TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma. Cancer Research. 66: 9385-92. PMID 17018592 DOI: 10.1158/0008-5472.Can-06-0590  0.419
2006 Yau WL, Lung HL, Zabarovsky ER, Lerman MI, Sham JS, Chua DT, Tsao SW, Stanbridge EJ, Lung ML. Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 119: 2821-6. PMID 16929489 DOI: 10.1002/Ijc.22232  0.419
2006 Wang XQ, Redpath JL, Fan ST, Stanbridge EJ. ATR dependent activation of Chk2. Journal of Cellular Physiology. 208: 613-9. PMID 16741947 DOI: 10.1002/Jcp.20700  0.313
2006 Kaluz S, Kaluzová M, Stanbridge EJ. The role of extracellular signal-regulated protein kinase in transcriptional regulation of the hypoxia marker carbonic anhydrase IX. Journal of Cellular Biochemistry. 97: 207-16. PMID 16270297 DOI: 10.1002/Jcb.20633  0.337
2006 Yi Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI, Stanbridge EJ, Lung ML. Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas. Cancer Letters. 234: 184-92. PMID 15885884 DOI: 10.1016/J.Canlet.2005.03.036  0.445
2005 Sobhanifar S, Aquino-Parsons C, Stanbridge EJ, Olive P. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors. Cancer Research. 65: 7259-66. PMID 16103077 DOI: 10.1158/0008-5472.Can-04-4480  0.321
2005 Lung HL, Bangarusamy DK, Xie D, Cheung AK, Cheng Y, Kumaran MK, Miller L, Liu ET, Guan XY, Sham JS, Fang Y, Li L, Wang N, Protopopov AI, Zabarovsky ER, ... ... Stanbridge EJ, et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene. 24: 6525-32. PMID 16007174 DOI: 10.1038/Sj.Onc.1208812  0.376
2005 McDaniel LD, Tomkins DJ, Stanbridge EJ, Somerville MJ, Friedberg EC, Schultz RA. Mapping of a single locus capable of complementing the defective heterochromatin phenotype of Roberts syndrome cells. American Journal of Human Genetics. 77: 132-9. PMID 15887093 DOI: 10.1086/431328  0.367
2005 Ko JM, Yau WL, Chan PL, Lung HL, Yang L, Lo PH, Tang JC, Srivastava G, Stanbridge EJ, Lung ML. Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor-suppressive regions to 14q32. Genes, Chromosomes & Cancer. 43: 284-93. PMID 15834943 DOI: 10.1002/Gcc.20190  0.411
2005 Yang L, Leung AC, Ko JM, Lo PH, Tang JC, Srivastava G, Oshimura M, Stanbridge EJ, Daigo Y, Nakamura Y, Tang CM, Lau KW, Law S, Lung ML. Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma. Oncogene. 24: 697-705. PMID 15580306 DOI: 10.1038/Sj.Onc.1208179  0.419
2004 Lung HL, Cheng Y, Kumaran MK, Liu ET, Murakami Y, Chan CY, Yau WL, Ko JM, Stanbridge EJ, Lung ML. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 112: 628-35. PMID 15382043 DOI: 10.1002/Ijc.20454  0.426
2004 Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, Kuzmin I, Minna JD, Stanbridge E, Braga E, Kashuba VI, Klein G, Lerman MI, Zabarovsky ER. Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Research. 64: 6438-43. PMID 15374952 DOI: 10.1158/0008-5472.Can-03-3869  0.418
2004 Kaluzová M, Kaluz S, Lerman MI, Stanbridge EJ. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX. Molecular and Cellular Biology. 24: 5757-66. PMID 15199132 DOI: 10.1128/Mcb.24.13.5757-5766.2004  0.311
2004 Duh FM, Fivash M, Moody M, Li Lung M, Guo X, Stanbridge E, Dean M, Voevoda M, Hu LF, Kashuba V, Zabarovsky ER, Qian CN, Godbole S, Tean Teh B, Lerman MI. Characterization of a new SNP c767A/T (Arg222Trp) in the candidate TSG FUS2 on human chromosome 3p21.3: prevalence in Asian populations and analysis of association with nasopharyngeal cancer. Molecular and Cellular Probes. 18: 39-44. PMID 15036368 DOI: 10.1016/J.Mcp.2003.09.002  0.304
2004 Kaluzová M, Kaluz S, Stanbridge EJ. High cell density induces expression from the carbonic anhydrase 9 promoter. Biotechniques. 36: 228-30, 232, 234. PMID 14989086 DOI: 10.2144/04362Bm05  0.313
2004 Mendonca MS, Farrington DL, Mayhugh BM, Qin Y, Temples T, Comerford K, Chakrabarti R, Zainabadi K, Redpath JL, Stanbridge EJ, Srivatsan ES. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells. Genes, Chromosomes & Cancer. 39: 277-87. PMID 14978789 DOI: 10.1002/Gcc.20007  0.458
2004 Cheng Y, Lung HL, Wong PS, Hao DC, Man CS, Stanbridge EJ, Lungi ML. Chromosome 13q12 region critical for the viability and growth of nasopharyngeal carcinoma hybrids International Journal of Cancer. 109: 357-362. PMID 14961573 DOI: 10.1002/Ijc.11704  0.436
2003 Cheng Y, Ko JM, Lung HL, Lo PH, Stanbridge EJ, Lung ML. Monochromosome transfer provides functional evidence for growth-suppressive genes on chromosome 14 in nasopharyngeal carcinoma. Genes, Chromosomes & Cancer. 37: 359-68. PMID 12800147 DOI: 10.1002/Gcc.10228  0.415
2003 Leslie Redpath J, Bengtsson U, DeSimone J, Lao X, Wang X, Stanbridge EJ. Sticky anaphase aberrations after G2-phase arrest of gamma-irradiated human skin fibroblasts: TP53 independence of formation and TP53 dependence of consequences. Radiation Research. 159: 57-71. PMID 12492369 DOI: 10.1667/0033-7587(2003)159[0057:Saaagp]2.0.Co;2  0.345
2002 Srivatsan ES, Chakrabarti R, Zainabadi K, Pack SD, Benyamini P, Mendonca MS, Yang PK, Kang K, Motamedi D, Sawicki MP, Zhuang Z, Jesudasan RA, Bengtsson U, Sun C, Roe BA, ... Stanbridge EJ, et al. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer. Oncogene. 21: 5631-42. PMID 12165862 DOI: 10.1038/Sj.Onc.1205698  0.433
2002 Cheng Y, Chakrabarti R, Garcia-Barcelo M, Ha TJ, Srivatsan ES, Stanbridge EJ, Lung ML. Mapping of nasopharyngeal carcinoma tumor-suppressive activity to a 1.8-megabase region of chromosome band 11q13. Genes, Chromosomes & Cancer. 34: 97-103. PMID 11921287 DOI: 10.1002/Gcc.10048  0.412
2002 Li H, Myeroff L, Kasturi L, Krumroy L, Schwartz S, Willson JK, Stanbridge E, Casey G, Markowitz S. Chromosomal autonomy of hMLH1 methylation in colon cancer. Oncogene. 21: 1443-9. PMID 11857087 DOI: 10.1038/Sj/Onc/1205247  0.346
2001 Li Q, Qi B, Oka K, Shimakage M, Yoshioka N, Inoue H, Hakura A, Kodama K, Stanbridge EJ, Yutsudo M. Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene. 20: 3929-36. PMID 11494121 DOI: 10.1038/Sj.Onc.1204536  0.336
2001 Gupta S, Stuffrein S, Plattner R, Tencati M, Gray C, Whang YE, Stanbridge EJ. Role of phosphoinositide 3-kinase in the aggressive tumor growth of HT1080 human fibrosarcoma cells Molecular and Cellular Biology. 21: 5846-5856. PMID 11486024 DOI: 10.1128/Mcb.21.17.5846-5856.2001  0.598
2001 Cao JN, Gao TW, Stanbridge EJ, Irie R. RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testis Journal of the National Cancer Institute. 93: 1159-1165. PMID 11481388 DOI: 10.1093/Jnci/93.15.1159  0.35
2001 Tsujimoto H, Nishizuka S, Redpath LJ, Stanbridge EJ. Examination of the oncogenic potential of H19 gene in HeLa x normal human fibroblast hybrid cells International Journal of Oncology. 19: 89-95. PMID 11408927 DOI: 10.3892/Ijo.19.1.89  0.393
2001 Gupta S, Stanbridge EJ. Paired human fibrosarcoma cell lines that possess or lack endogenous mutant N-ras alleles as experimental model for Ras signaling pathways Methods in Enzymology. 333: 290-306. PMID 11400345 DOI: 10.1016/S0076-6879(01)33064-1  0.377
2001 Kong XT, Gao H, Stanbridge EJ. Mechanisms of Differential Activation of Target Gene Promoters by p53 Hinge Domain Mutants with Impaired Apoptotic Function Journal of Biological Chemistry. 276: 32990-33000. PMID 11395510 DOI: 10.1074/Jbc.M103681200  0.303
2001 Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G, Zabarovsky ER. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. 98: 7504-9. PMID 11390984 DOI: 10.1073/Pnas.131216298  0.405
2001 Nishizuka S, Tsujimoto H, Stanbridge EJ. Detection of differentially expressed genes in HeLa x fibroblast hybrids using subtractive suppression hybridization Cancer Research. 61: 4536-4540. PMID 11389086  0.31
2001 Backsch C, Wagenbach N, Nonn M, Leistritz S, Stanbridge E, Schneider A, Dürst M. Microcell-mediated transfer of chromosome 4 into HeLa cells suppresses telomerase activity. Genes, Chromosomes & Cancer. 31: 196-8. PMID 11319808 DOI: 10.1002/Gcc.1134  0.426
2001 Nishizuka S, Winokur ST, Simon M, Martin J, Tsujimoto H, Stanbridge EJ. Oligonucleotide microarray expression analysis of genes whose expression is correlated with tumorigenic and non-tumorigenic phenotype of HeLa × human fibroblast hybrid cells Cancer Letters. 165: 201-209. PMID 11275370 DOI: 10.1016/S0304-3835(01)00437-2  0.369
2001 Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI, Stanbridge EJ. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. The American Journal of Pathology. 158: 905-19. PMID 11238039 DOI: 10.1016/S0002-9440(10)64038-2  0.381
2000 Gupta S, Plattner R, Der CJ, Stanbridge EJ. Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: Evidence for a potential novel pathway Molecular and Cellular Biology. 20: 9294-9306. PMID 11094080 DOI: 10.1128/Mcb.20.24.9294-9306.2000  0.673
2000 Johnsen JI, Aurelio ON, Kwaja Z, Jörgensen GE, Pellegata NS, Plattner R, Stanbridge EJ, Cajot JF. p53-Mediated negative regulation of stathmin/Op18 expression is associated with G2/M cell-cycle arrest International Journal of Cancer. 88: 685-691. PMID 11072234 DOI: 10.1002/1097-0215(20001201)88:5<685::Aid-Ijc1>3.0.Co;2-Z  0.588
2000 Srivatsan ES, Bengtsson U, Manickam P, Benyamini P, Chandrasekharappa SC, Sun C, Stanbridge EJ, Redpath JL. Interstitial deletion of 11q13 sequences in HeLa cells. Genes, Chromosomes & Cancer. 29: 157-65. PMID 10959095 DOI: 10.1002/1098-2264(2000)9999:9999<::Aid-Gcc1024>3.0.Co;2-P  0.442
2000 Cheng Y, Stanbridge EJ, Kong H, Bengtsson U, Lerman MI, Lung ML. A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach. Genes, Chromosomes & Cancer. 28: 82-91. PMID 10738306 DOI: 10.1002/(Sici)1098-2264(200005)28:1<82::Aid-Gcc10>3.0.Co;2-8  0.44
2000 DeSimone JN, Dolezalova H, Redpath JL, Stanbridge EJ. Prolonged cell cycle arrest in irradiated human diploid skin fibroblasts: The role of nutrient deprivation Radiation Research. 153: 131-143. PMID 10629612 DOI: 10.1667/0033-7587(2000)153[0131:Pccaii]2.0.Co;2  0.345
2000 Aurelio ON, Kong XT, Gupta S, Stanbridge EJ. p53 Mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines Molecular and Cellular Biology. 20: 770-778. PMID 10629033 DOI: 10.1128/Mcb.20.3.770-778.2000  0.337
1999 Tsujimoto H, Nishizuka S, Redpath JL, Stanbridge EJ. Differential gene expression in tumorigenic and nontumorigenic HeLa x normal human fibroblast hybrid cells Molecular Carcinogenesis. 26: 298-304. PMID 10569806 DOI: 10.1002/(Sici)1098-2744(199912)26:4<298::Aid-Mc8>3.0.Co;2-M  0.41
1999 Kuzmin I, Geil L, Ge H, Bengtsson U, Duh FM, Stanbridge EJ, Lerman MI. Analysis of aberrant methylation of the VHL gene by transgenes, monochromosome transfer, and cell fusion. Oncogene. 18: 5672-9. PMID 10523847 DOI: 10.1038/Sj.Onc.1202959  0.38
1999 Oka K, Tomonaga Y, Nakazawa T, Ge HY, Bengtsson U, Stanbridge EJ, Yoshioka N, Li Q, Hakura A, Yutsudo M. Malignant transformation of human diploid fibroblasts and suppression of their anchorage independence by introduction of chromosome 13. Genes, Chromosomes & Cancer. 26: 47-53. PMID 10441005 DOI: 10.1002/(Sici)1098-2264(199909)26:1<47::Aid-Gcc7>3.0.Co;2-8  0.464
1999 Suzuki T, Iwazaki A, Katagiri H, Oka Y, Redpath JL, Stanbridge EJ, Kitagawa T. Enhanced expression of glucose transporter GLUT3 in tumorigenic HeLa cell hybrids associated with tumor suppressor dysfunction European Journal of Biochemistry. 262: 534-540. PMID 10336639 DOI: 10.1046/J.1432-1327.1999.00421.X  0.42
1999 Mills AA, Mills MJ, Gardiner DM, Bryant SV, Stanbridge EJ. Analysis of the pattern of QM expression during mouse development. Differentiation; Research in Biological Diversity. 64: 161-71. PMID 10234813 DOI: 10.1046/J.1432-0436.1999.6430161.X  0.368
1999 Plattner R, Gupta S, Khosravi-Far R, Sato KY, Perucho M, Der CJ, Stanbridge EJ. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells Oncogene. 18: 1807-1817. PMID 10086335 DOI: 10.1038/Sj.Onc.1202482  0.673
1999 Bleuel K, Popp S, Fusenig NE, Stanbridge EJ, Boukamp P. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization Proceedings of the National Academy of Sciences of the United States of America. 96: 2065-2070. PMID 10051595 DOI: 10.1073/Pnas.96.5.2065  0.412
1998 Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. Regulation of cell death protease caspase-9 by phosphorylation Science. 282: 1318-1321. PMID 9812896 DOI: 10.1126/Science.282.5392.1318  0.309
1998 Ivanov SV, Kuzmin I, Wei MH, Pack S, Geil L, Johnson BE, Stanbridge EJ, Lerman MI. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proceedings of the National Academy of Sciences of the United States of America. 95: 12596-601. PMID 9770531 DOI: 10.1073/Pnas.95.21.12596  0.342
1998 Suzuki T, Suzuki Y, Hanada K, Hashimoto A, Redpath JL, Stanbridge EJ, Nishijima M, Kitagawa T. Reduction of caveolin-1 expression in tumorigenic human cell hybrids Journal of Biochemistry. 124: 383-388. PMID 9685730  0.375
1998 De Feijter-Rupp HL, Hayashi T, Kalimi GH, Edwards P, Redpath JL, Chang CC, Stanbridge EJ, Trosko JE. Restored gap junctional communication in non-tumorigenic HeLa-normal human fibroblast hybrids Carcinogenesis. 19: 747-754. PMID 9635859 DOI: 10.1093/Carcin/19.5.747  0.368
1998 Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI, Stanbridge EJ. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proceedings of the National Academy of Sciences of the United States of America. 95: 3042-7. PMID 9501212 DOI: 10.1073/Pnas.95.6.3042  0.401
1998 Mendonca MS, Howard K, Fasching CL, Farrington DL, Desmond LA, Stanbridge EJ, Redpath JL. Loss of suppressor loci on chromosomes 11 and 14 may be required for radiation-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids. Radiation Research. 149: 246-55. PMID 9496887 DOI: 10.2307/3579957  0.325
1998 Nguyen YH, Mills AA, Stanbridge EJ. Assembly of the QM protein onto the 60S ribosomal subunit occurs in the cytoplasm. Journal of Cellular Biochemistry. 68: 281-5. PMID 9443083 DOI: 10.1002/(Sici)1097-4644(19980201)68:2<281::Aid-Jcb14>3.0.Co;2-I  0.323
1998 Szeles A, Yang Y, Sandlund AM, Kholodnyuk I, Kiss H, Kost-Alimova M, Zabarovsky ER, Stanbridge E, Klein G, Imreh S. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM. Genes, Chromosomes & Cancer. 20: 329-36. PMID 9408748 DOI: 10.1002/(Sici)1098-2264(199712)20:4<329::Aid-Gcc3>3.0.Co;2-3  0.4
1997 Noto Y, Iwazaki A, Nagao J, Sumiyama Y, Redpath JL, Stanbridge EJ, Kitagawa T. Altered N-glycosylation of glucose transporter-1 associated with radiation-induced tumorigenesis of human cell hybrids Biochemical and Biophysical Research Communications. 240: 395-398. PMID 9388489 DOI: 10.1006/bbrc.1997.7650  0.312
1997 Imreh S, Kost-Alimova M, Kholodnyuk I, Yang Y, Szeles A, Kiss H, Liu Y, Foster K, Zabarovsky E, Stanbridge E, Klein G. Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth Genes Chromosomes and Cancer. 20: 224-233. PMID 9365829 DOI: 10.1002/(Sici)1098-2264(199711)20:3<224::Aid-Gcc2>3.0.Co;2-4  0.402
1997 Larson AA, Liao SY, Stanbridge EJ, Cavenee WK, Hampton GM. Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Research. 57: 4171-6. PMID 9331069 DOI: 10.1097/00128360-199810000-00011  0.338
1997 Reid LH, Davies C, Cooper PR, Crider-Miller SJ, Sait SN, Nowak NJ, Evans G, Stanbridge EJ, deJong P, Shows TB, Weissman BE, Higgins MJ. A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. Genomics. 43: 366-75. PMID 9268640 DOI: 10.1006/Geno.1997.4826  0.392
1997 Liao SY, Aurelio ON, Jan K, Zavada J, Stanbridge EJ. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney Cancer Research. 57: 2827-2831. PMID 9230182 DOI: 10.1097/00005392-199805000-00146  0.309
1997 Loftus TM, Nguyen YH, Stanbridge EJ. The QM protein associates with ribosomes in the rough endoplasmic reticulum. Biochemistry. 36: 8224-30. PMID 9204867 DOI: 10.1021/Bi970288D  0.359
1997 Kholodnyuk I, Kost-Alimova M, Kashuba V, Gizatulin R, Szeles A, Stanbridge EJ, Zabarovsky ER, Klein G, Imreh S. A 3p21.3 region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumor growth in SCID mice. Genes, Chromosomes & Cancer. 18: 200-11. PMID 9071573 DOI: 10.1002/(Sici)1098-2264(199703)18:3<200::Aid-Gcc6>3.0.Co;2-5  0.418
1997 Lanyi A, Li B, Li S, Talmadge CB, Brichacek B, Davis JR, Kozel BA, Trask B, van den Engh G, Uzvolgyi E, Stanbridge EJ, Nelson DL, Chinault C, Heslop H, Gross TG, et al. A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus. Genomics. 39: 55-65. PMID 9027486 DOI: 10.1006/Geno.1996.4466  0.356
1996 Pellegata NS, Antoniono RJ, Redpath JL, Stanbridge EJ. DNA damage and p53-mediated cell cycle arrest: A reevaluation Proceedings of the National Academy of Sciences of the United States of America. 93: 15209-15214. PMID 8986789 DOI: 10.1073/Pnas.93.26.15209  0.332
1996 Brewer CA, Liao SY, Wilczynski SP, Pastorekova S, Pastorek J, Zavada J, Kurosaki T, Manetta A, Berman ML, DiSaia PJ, Stanbridge EJ. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN Gynecologic Oncology. 63: 337-344. PMID 8946869 DOI: 10.1006/Gyno.1996.0333  0.339
1996 Jongmans W, Verhaegh GW, Jaspers NG, Demant P, Natarajan AT, Shiloh Y, Oshimura M, Stanbridge EJ, Athwal RS, Cuthbert AP, Newbold RF, Lohman PH, Zdzienicka MZ. The defect in the AT-like hamster cell mutants is complemented by mouse chromosome 9 but not by any of the human chromosomes. Mutation Research. 364: 91-102. PMID 8879275 DOI: 10.1016/0921-8777(96)00027-4  0.398
1996 Reid LH, West A, Gioeli DG, Phillips KK, Kelleher KF, Araujo D, Stanbridge EJ, Dowdy SF, Gerhard DS, Weissman BE. Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay. Human Molecular Genetics. 5: 239-47. PMID 8824880 DOI: 10.1093/Hmg/5.2.239  0.454
1996 Plattner R, Anderson MJ, Sato KY, Fasching CL, Der CJ, Stanbridge EJ. Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proceedings of the National Academy of Sciences of the United States of America. 93: 6665-70. PMID 8692875 DOI: 10.1073/Pnas.93.13.6665  0.662
1996 Sumegi J, Wang JY, Zhen DK, Eudy JD, Talmadge CB, Li BF, Berglund P, Weston MD, Yao SF, Ma-Edmonds M, Overbeck L, Kelley PM, Zabarovsky E, Uzvolgyi E, Stanbridge EJ, et al. The construction of a yeast artificial chromosome (YAC) contig in the vicinity of the Usher syndrome type IIa (USH2A) gene in 1q41. Genomics. 35: 79-86. PMID 8661107 DOI: 10.1006/Geno.1996.0325  0.317
1996 Szeles A, Kholodnyuk I, Bajalica S, Lindblom A, Lushnikova T, Kashuba V, Nordenskjöld M, Stanbridge E, Zabarovsky E, Klein G, Imreh S. Localization and ordering of the human 3PK gene and five other human chromosome 3 markers. Attempt to establish the borders of the nonrandomly eliminated putative chromosome 3 tumor suppressor regions in mouse-human microcell hybrid derived SCID tumors Cancer Genetics and Cytogenetics. 91: 186. DOI: 10.1016/S0165-4608(97)82677-5  0.414
1996 Imreh S, Kholodniuk I, Szeles A, Kost M, Kiss H, Yang Y, Zabarovsky E, Marshall B, Foster K, Ingvarsson S, Chevrette M, Stanbridge E, Klein G. “Elimination test”: Solid tumor progression model based on the nonrandom changes of human chromosome 3 in monochromosomal microcell hybrid Cancer Genetics and Cytogenetics. 91: 185. DOI: 10.1016/S0165-4608(97)82675-1  0.379
1995 McMaster ML, Gessler M, Stanbridge EJ, Weissman BE. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line Cell Growth and Differentiation. 6: 1609-1617. PMID 9019166  0.324
1995 Kitagawa T, Tsuruhara Y, Hayashi M, Endo T, Stanbridge EJ. A tumor-associated glycosylation change in the glucose transporter GLUT1 controlled by tumor suppressor function in human cell hybrids Journal of Cell Science. 108: 3735-3743. PMID 8719880  0.313
1995 Talmadge CB, Zhen DK, Wang JY, Berglund P, Li BF, Weston MD, Kimberling WJ, Zabarovsky ER, Stanbridge EJ, Klein G. Construction and characterization of a NotI linking library from human chromosome region 1q25-qter. Genomics. 29: 105-14. PMID 8530059 DOI: 10.1006/Geno.1995.1220  0.361
1995 Sensi A, Bonfatti A, Gruppioni R, Gualandi F, Rimessi P, Trabanelli C, Barbanti-Brodano G, Stanbridge EJ. Complementation of bloom cellular phenotype by human chromosome 15. Cancer Genetics and Cytogenetics. 80: 167. PMID 7736439 DOI: 10.1016/0165-4608(94)00169-C  0.37
1995 Boukamp P, Peter W, Pascheberg U, Altmeier S, Fasching C, Stanbridge EJ, Fusenig NE. Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss Oncogene. 11: 961-969. PMID 7675455  0.33
1995 Kashuba VI, Szeles A, Allikmets R, Nilsson AS, Bergerheim US, Modi W, Grafodatsky A, Dean M, Stanbridge EJ, Winberg G. A group of NotI jumping and linking clones cover 2.5 Mb in the 3p21-p22 region suspected to contain a tumor suppressor gene. Cancer Genetics and Cytogenetics. 81: 144-50. PMID 7621411 DOI: 10.1016/0165-4608(94)00215-W  0.398
1995 Mendonca MS, Fasching CL, Srivatsan ES, Stanbridge EJ, Redpath JL. Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids Radiation Research. 143: 34-44. PMID 7597142 DOI: 10.2307/3578923  0.457
1995 Menke AL, van Ham RC, Sonneveld E, Shvarts A, Stanbridge EJ, Miyagawa K, van der Eb AJ, Jochemsen AG. Human chromosome 11 suppresses the tumorigenicity of adenovirus transformed baby rat kidney cells: involvement of the Wilms' tumor 1 gene. International Journal of Cancer. Journal International Du Cancer. 63: 76-85. PMID 7558457 DOI: 10.1002/Ijc.2910630115  0.458
1994 Sabbioni S, Negrini M, Possati L, Bonfatti A, Corallini A, Sensi A, Stanbridge EJ, Barbanti-Brodano G. Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells. International Journal of Cancer. Journal International Du Cancer. 57: 185-91. PMID 8157356 DOI: 10.1002/Ijc.2910570210  0.469
1994 Lee JY, Koi M, Stanbridge EJ, Oshimura M, Kumamoto AT, Feinberg AP. Simple purification of human chromosomes to homogeneity using muntjac hybrid cells Nature Genetics. 7: 29-33. PMID 8075635 DOI: 10.1038/Ng0594-29  0.406
1994 Zabarovsky ER, Kashuba VI, Kholodnyuk ID, Zabarovska VI, Stanbridge EJ, Klein G. Rapid Mapping of NotI Linking Clones with Differential Hybridization and Alu-PCR Genomics. 21: 486-489. PMID 7959723 DOI: 10.1006/Geno.1994.1305  0.323
1994 Stanbridge E, Farmer A, Mills A, Loftus T, Kongkasuriyachai D, Dowdy S, Weissman B. Molecular characterization of QM, a novel gene with properties consistent with tumor suppressor function Cold Spring Harbor Symposia On Quantitative Biology. 59: 573-576. PMID 7587114 DOI: 10.1101/Sqb.1994.059.01.064  0.317
1994 Imreh S, Kholodnyuk I, Allikmetts R, Stanbridge EJ, Zabarovsky ER, Klein G. Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice Genes Chromosomes and Cancer. 11: 237-245. PMID 7533527 DOI: 10.1002/Gcc.2870110406  0.431
1994 Gualandi F, Morelli C, Pavan JV, Rimessi P, Sensi A, Bonfatti A, Gruppioni R, Possati L, Stanbridge EJ, Barbanti-Brodano G. Induction of senescence and control of tumorigenicity in BK virus transformed mouse cells by human chromosome 6. Genes, Chromosomes & Cancer. 10: 77-84. PMID 7520270 DOI: 10.1002/Gcc.2870100202  0.469
1994 Anderson MJ, Casey G, Fasching CL, Stanbridge EJ. Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080. Genes, Chromosomes & Cancer. 9: 266-81. PMID 7519049 DOI: 10.1002/Gcc.2870090407  0.424
1994 Anderson MJ, Fasching CL, Xu HJ, Benedict WF, Stanbridge EJ. Chromosome 13 transfer provides evidence for regulation of RB1 protein expression. Genes, Chromosomes & Cancer. 9: 251-60. PMID 7519047 DOI: 10.1002/Gcc.2870090405  0.462
1994 Hampton G, Penny L, Baergen R, Larson A, Brewer C, Liao S, Busby-Earle R, Williams A, Steel C, Bird C, Stanbridge E, Evans G. Sub-chromosomal localization of a putative tumor-suppressor gene involved in cervical cancers to 11q22–q24 Cancer Genetics and Cytogenetics. 77: 196. DOI: 10.1016/0165-4608(94)90420-0  0.371
1994 Imreh S, Kholodnyuk I, Stanbridge E, Zabarovsky E, Klein G. Nonrandom loss of human chromosome 3 fragments in scid tumors of mouse/human microcell hybrids. A potential method for tumor suppressor gene isolation? Cancer Genetics and Cytogenetics. 77: 153. DOI: 10.1016/0165-4608(94)90249-6  0.403
1993 Anderson MJ, Stanbridge EJ. Tumor suppressor genes studied by cell hybridization and chromosome transfer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 7: 826-33. PMID 8344482 DOI: 10.1096/Fasebj.7.10.8344482  0.43
1993 Casey G, Plummer S, Hoeltge G, Scanlon D, Fasching C, Stanbridge EJ. Functional evidence for a breast cancer growth suppressor gene on chromosome 17 Human Molecular Genetics. 2: 1921-1927. PMID 8281156 DOI: 10.1093/Hmg/2.11.1921  0.405
1993 Gross MM, Janiaud P, Stanbridge EJ. Effect of retroviral integration on control of expression of a tumor marker in HeLa cells Molecular Carcinogenesis. 8: 89-95. PMID 7691070 DOI: 10.1002/Mc.2940080205  0.43
1992 Zabarovsky ER, Boldog F, Erlandsson R, Kashuba VI, Allikmets RL, Marcsek Z, Kisselev LL, Stanbridge E, Klein G, Sumegi J. New strategy for mapping the human genome based on a novel procedure for construction of jumping libraries. Genomics. 11: 1030-9. PMID 1783374 DOI: 10.1016/0888-7543(91)90029-E  0.339
1992 Rodriguez-Alfageme C, Stanbridge EJ, Astrin SM. Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer Proceedings of the National Academy of Sciences of the United States of America. 89: 1482-1486. PMID 1741403 DOI: 10.1073/Pnas.89.4.1482  0.454
1992 Latham KM, Stanbridge EJ. Examination of the Oncogenic Potential of a Tumor-associated Antigen, Intestinal Alkaline Phosphatase, in HeLa x Fibroblast Cell Hybrids Cancer Research. 52: 616-622. PMID 1732049  0.328
1992 Meese EU, Witkowski CM, Zoghbi HY, Stanbridge EJ, Meltzer PS, Trent JM. Development and utilization of a somatic cell hybrid mapping panel to assign NotI linking probes to the long arm of human chromosome 6. Genomics. 12: 542-8. PMID 1559705 DOI: 10.1016/0888-7543(92)90446-Y  0.362
1992 Negrini M, Castagnoli A, Sabbioni S, Recanatini E, Giovannini G, Possati L, Stanbridge EJ, Nenci I, Barbanti-Brodano G. Suppression of tumorigenesis by the breast cancer cell line MCF-7 following transfer of a normal human chromosome 11. Oncogene. 7: 2013-8. PMID 1408142  0.34
1992 Goyette MC, Cho K, Fasching CL, Levy DB, Kinzler KW, Paraskeva C, Vogelstein B, Stanbridge EJ. Progression of Colorectal Cancer Is Associated with Multiple Tumor Suppressor Gene Defects but Inhibition of Tumorigenicity Is Accomplished by Correction of Any Single Defect via Chromosome Transfer Molecular and Cellular Biology. 12: 1387-1395. PMID 1347643 DOI: 10.1128/Mcb.12.3.1387  0.454
1992 Parshad R, Price FM, Oshimura M, Barrett JC, Satoh H, Weissman BE, Stanbridge EJ, Sanford KK. Complementation of a DNA repair deficiency in six human tumor cell lines by chromosome 11. Human Genetics. 88: 524-8. PMID 1312990 DOI: 10.1007/Bf00219338  0.32
1991 Zabarovsky ER, Boldog F, Thompson T, Scanlon D, Winberg G, Marcsek Z, Erlandsson R, Stanbridge EJ, Klein G, Sümegi J. Construction of a human chromosome 3 specific NotI linking library using a novel cloning procedure. Nucleic Acids Research. 18: 6319-24. PMID 2243778 DOI: 10.1093/Nar/18.21.6319  0.363
1991 Lambert C, Schultz RA, Smith M, Wagner-Mcpherson C, Mcdaniel LD, Donlon T, Stanbridge EJ, Friedberg EC. Functional complementation of ataxia-telangiectasia group D (AT-D) cells by microcell-mediated chromosome transfer and mapping of the AT-D locus to the region 11q22-23 Proceedings of the National Academy of Sciences of the United States of America. 88: 5907-5911. PMID 2062869 DOI: 10.1073/Pnas.88.13.5907  0.382
1991 Mendonca MS, Antoniono RJ, Latham KM, Stanbridge EJ, Redpath JL. Characterization of Intestinal Alkaline Phosphatase Expression and the Tumorigenic Potential of γ-irradiated HeLa × Fibroblast Cell Hybrids Cancer Research. 51: 4455-4462. PMID 1868467  0.351
1991 Kwiatkowska B, McCullough JL, Weinstein GD, Stanbridge EJ. Specificity of human keratinocyte X HeLa cell hybrid murine monoclonal antibodies International Journal of Dermatology. 30: 860-863. PMID 1816129 DOI: 10.1111/J.1365-4362.1991.Tb04352.X  0.33
1991 Bader SA, Fasching C, Brodeur GM, Stanbridge EJ. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells Cell Growth &Amp; Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 2: 245-255. PMID 1679663  0.321
1991 Mendonca MS, Boukamp P, Stanbridge EJ, Redpath JL. The radiosensitivity of human keratinocytes: Influence of activated c-h-ras oncogene expression and tumorigenicity International Journal of Radiation Biology. 59: 1195-1206. PMID 1675238 DOI: 10.1080/09553009114551071  0.33
1991 Dowdy SF, Lai Km, Weissman BE, Matsui Y, Hogan BLM, Stanbridge EJ. The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic wilms' microcell hybrid cells Nucleic Acids Research. 19: 5763-5769. PMID 1658743 DOI: 10.1093/Nar/19.20.5763  0.422
1991 Dowdy SF, Fasching CL, Araujo D, Lai KM, Livanos E, Weissman BE, Stanbridge EJ. Suppression of tumorigenicity in wilms tumor by the p15.5-p14 region of chromosome 11 Science. 254: 293-295. PMID 1656527 DOI: 10.1126/Science.1656527  0.4
1991 Wheeler TT, Xiao JP, Dowdy SF, Stanbridge EJ, Young DA. Suppression of tumorigenicity of a Wilms' tumor cell line is associated with a decrease in synthesis of two proteins Oncogene. 6: 1903-1907. PMID 1656366  0.363
1991 Dowdy SF, Weissman BE, Stanbridge EJ. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma Journal of Cellular Physiology. 147: 248-255. PMID 1645741 DOI: 10.1002/Jcp.1041470209  0.417
1991 Trent J, Meese E, Stanbridge E. Cytogenetic and molecular analysis of human malignant melanoma: The search for a suppressor gene on chromosome 6. Cancer Genetics and Cytogenetics. 52: 255. DOI: 10.1016/0165-4608(91)90544-5  0.377
1990 Fusenig NE, Boukamp P, Breitkreutz D, Hülsen A, Petrusevska S, Cerutti P, Stanbridge E. In vitro transformation of human skin epithelial cells: Role of RAS oncogene in malignant progression Toxicology in Vitro. 4: 627-634. PMID 20702246 DOI: 10.1016/0887-2333(90)90132-D  0.404
1990 McKeehan WL, Barnes D, Reid L, Stanbridge E, Murakami H, Sato GH. Frontiers in mammalian cell culture In Vitro Cellular and Developmental Biology - Animal. 26: 9-23. PMID 2407711 DOI: 10.1007/Bf02624149  0.341
1990 Stanbridge EJ. Identifying tumor suppressor genes in human colorectal cancer Science. 247: 12-13. PMID 2403692 DOI: 10.1126/Science.2403692  0.34
1990 Latham KM, Stanbridge EJ. Identification of the HeLa tumor-associated antigen, p75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation Proceedings of the National Academy of Sciences of the United States of America. 87: 1263-1267. PMID 2304898 DOI: 10.1073/Pnas.87.4.1263  0.38
1990 Trent JM, Stanbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowski CM, Nagle RB. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6 Science. 247: 568-571. PMID 2300817 DOI: 10.1126/Science.2300817  0.441
1990 Dowdy SF, Scanlon DJ, Fasching CL, Casey G, Stanbridge EJ. Irradiation microcell-mediated chromosome transfer (XMMCT): The generation of specific chromosomal arm deletions Genes Chromosomes and Cancer. 2: 318-327. PMID 2268580 DOI: 10.1002/Gcc.2870020410  0.384
1990 Stanbridge EJ, Nowell PC. Origins of human cancer revisited Cell. 63: 867-874. PMID 2257627 DOI: 10.1016/0092-8674(90)90490-6  0.326
1990 Stanbridge EJ. Human tumor suppressor genes Annual Review of Genetics. 24: 615-657. PMID 2088179 DOI: 10.1146/Annurev.Ge.24.120190.003151  0.353
1990 Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor Cell. 60: 535-545. PMID 1967982 DOI: 10.1016/0092-8674(90)90657-Z  0.349
1989 Shimizu H, Wyatt D, Knowles RD, Bucana CD, Stanbridge EJ, Kleinerman ES. Human monocytes selectively bind to cells expressing the tumorigenic phenotype Cancer Immunology Immunotherapy. 28: 185-192. PMID 2784354 DOI: 10.1007/Bf00204987  0.364
1989 Stanbridge EJ. The evidence for human tumor suppressor genes Princess Takamatsu Symposia. 20: 3-13. PMID 2577336  0.356
1989 Stanbridge EJ. A genetic basis for tumour suppression Ciba Foundation Symposium. 142: 149-159; discussion . PMID 2545419  0.32
1989 Stanbridge EJ, Cavenee WK. 11 Heritable Cancer and Tumor Suppressor Genes: A Tentative Connection Cold Spring Harbor Monograph Archive. 18: 281-306. DOI: 10.1101/087969336.18.281  0.45
1988 Sun C, Redpath JL, Colman M, Stanbridge EJ. Further studies on the radiation-induced expression of a tumor-specific antigen in human cell hybrids Radiation Research. 114: 84-93. PMID 3353509 DOI: 10.2307/3577146  0.407
1987 Redpath JL, Sun C, Colman M, Stanbridge EJ. Neoplastic transformation of human hybrid cells by gamma radiation: a quantitative assay Radiation Research. 110: 468-472. PMID 3588851 DOI: 10.2307/3577013  0.327
1987 Tao W, Wilkinson J, Stanbridge EJ, Berns MW. Direct gene transfer into human cultured cells facilitated by laser micropuncture of the cell membrane Proceedings of the National Academy of Sciences of the United States of America. 84: 4180-4184. PMID 3473500 DOI: 10.1073/Pnas.84.12.4180  0.386
1987 Saxon PJ, Stanbridge EJ. Transfer and selective retention of single specific human chromosomes via microcell-mediated chromosome transfer Methods in Enzymology. 151: 313-325. PMID 3431447 DOI: 10.1016/S0076-6879(87)51026-6  0.396
1987 Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression Science. 236: 175-180. PMID 3031816 DOI: 10.1126/Science.3031816  0.475
1986 Sanford KK, Jones GM, Tarone RE, Parshad R, Stanbridge EJ, Wilkinson JE, Frost JK. Chromosomal radiosensitivity during the g2 cell cycle period and cytopathology of human normal x tumor cell hybrids Cancer Research. 46: 2045-2049. PMID 3948180  0.34
1986 Geiser AG, Der CJ, Marshall CJ, Stanbridge EJ. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells Proceedings of the National Academy of Sciences of the United States of America. 83: 5209-5213. PMID 3523486 DOI: 10.1073/Pnas.83.14.5209  0.585
1986 Saxon PJ, Srivatsan ES, Stanbridge EJ. Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells Embo Journal. 5: 3461-3466. PMID 2881780 DOI: 10.1002/J.1460-2075.1986.Tb04670.X  0.409
1986 Srivatsan ES, Benedict WF, Stanbridge EJ. Implication of Chromosome 11 in the Suppression of Neoplastic Expression in Human Cell Hybrids Cancer Research. 46: 6174-6179. PMID 2877730  0.324
1985 Saxon PJ, Srivatsan ES, Leipzig GV, Sameshima JH, Stanbridge EJ. Selective transfer of individual human chromosomes to recipient cells Molecular and Cellular Biology. 5: 140-146. PMID 3982414 DOI: 10.1128/Mcb.5.1.140  0.409
1985 Stanbridge EJ. A case for human tumor-suppressor genes Bioessays. 3: 252-255. PMID 3842600 DOI: 10.1002/Bies.950030605  0.406
1984 Benedict WF, Mark C, Stanbridge EJ, Weissman BE. Tumorigenicity of Human HT1080 Fibrosarcoma x Normal Fibroblast Hybrids: Chromosome Dosage Dependency Cancer Research. 44: 3471-3479. PMID 6744274  0.325
1984 Srivatsan ES, Stanbridge EJ, Saxon PJ, Stambrook PJ, Trill JJ, Tischfield JA. Plasmid, phage, and genomic DNA-mediated transfer and expression of prokaryotic and eukaryotic genes in cultured human cells Cytogenetic and Genome Research. 38: 227-234. PMID 6237889 DOI: 10.1159/000132065  0.38
1983 Weissman BE, Stanbridge EJ. Complementation of the tumorigenic phenotype in human cell hybrids Journal of the National Cancer Institute. 70: 667-672. PMID 6572754 DOI: 10.1093/Jnci/70.4.667  0.348
1982 Peehl DM, Stanbridge EJ. The role of differentiation in the suppression of tumorigenicity in human cell hybrids International Journal of Cancer. 30: 113-120. PMID 7118295 DOI: 10.1002/Ijc.2910300119  0.449
1982 Stanbridge EJ, Der CJ, Doersen CJ, Nishimi RY, Peehl DM, Weissman BE, Wilkinson JE. Human cell hybrids: Analysis of transformation and tumorigenicity Science. 215: 252-259. PMID 7053574 DOI: 10.1126/Science.7053574  0.556
1982 Stanbridge EJ, Rosen SW, Sussman HH. Expression of the α subunit of human chorionic gonadotropin is specifically correlated with tumorigenic expression in human cell hybrids Proceedings of the National Academy of Sciences of the United States of America. 79: 6242-6245. PMID 6959112 DOI: 10.1073/Pnas.79.20.6242  0.378
1982 Stanbridge EJ. Mycoplasma-lymphocyte interactions and their Possible role in immunopathologic manifestations of mycoplasmal disease Reviews of Infectious Diseases. 4: S219-S226. PMID 6126923 DOI: 10.1093/Clinids/4.Supplement_1.S219  0.331
1982 Doersen CJ, Stanbridge EJ. Nuclear inheritance of erythromycin resistance in human cells: New class of mitochondrial protein synthesis mutants Molecular and Cellular Biology. 2: 694-700. DOI: 10.1128/Mcb.2.6.694  0.302
1982 Doersen C, Stanbridge EJ. Cytoplasmic and Nuclear Inheritance of Erythromycin Resistance in Human Cells Cold Spring Harbor Monograph Archive. 12: 129-132. DOI: 10.1101/087969145.12.129  0.3
1981 Der CJ, Stanbridge EJ. A tumor-specific membrane phosphoprotein marker in human cell hybrids Cell. 26: 429-438. PMID 7326746 DOI: 10.1016/0092-8674(81)90212-9  0.58
1981 Stanbridge EJ, Flandermeyer RR, Daniels DW, Nelson-Rees WA. Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids Somatic Cell Genetics. 7: 699-712. PMID 7323948 DOI: 10.1007/Bf01538758  0.417
1981 Doersen CJ, Stanbridge EJ. Effects of mycoplasma contamination on phenotypic expression of mitochondrial mutants in human cells Molecular and Cellular Biology. 1: 321-329. PMID 6965101 DOI: 10.1128/Mcb.1.4.321  0.302
1981 Kluve B, Merrick WC, Stanbridge EJ, Gershman H. Mycoplasmas induce collagenase in BALB/c 3T3 cells Nature. 292: 855-857. PMID 6267475 DOI: 10.1038/292855A0  0.323
1981 Peehl DM, Stanbridge EJ. Characterization of human keratinocyte x HeLa somatic cell hybrids International Journal of Cancer. 27: 625-635. PMID 6169665 DOI: 10.1002/Ijc.2910270509  0.423
1980 Der CJ, Stanbridge EJ. Alterations in the extracellular matrix organization associated with the reexpression of tumorigenicity in human cell hybrids International Journal of Cancer. 26: 451-459. PMID 7251223 DOI: 10.1002/Ijc.2910260410  0.576
1980 Stanbridge EJ, Wilkinson J. Dissociation of anchorage independence from tumorigenicity in human cell hybrids International Journal of Cancer. 26: 1-8. PMID 7239708 DOI: 10.1002/Ijc.2910260102  0.433
1978 Der CJ, Stanbridge EJ. Lack of correlation between the decreased expression of cell surface LETS protein and tumorigenicity in human cell hybrids Cell. 15: 1241-1251. PMID 728999 DOI: 10.1016/0092-8674(78)90050-8  0.571
1978 Stanbridge EJ, Wilkinson J. Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control Proceedings of the National Academy of Sciences of the United States of America. 75: 1466-1469. PMID 274733 DOI: 10.1073/Pnas.75.3.1466  0.404
1976 Stanbridge EJ. Suppression of malignancy in human cells Nature. 260: 17-20. PMID 1264187 DOI: 10.1038/260017A0  0.372
1975 Stanbridge EJ, Tischfield JA, Schneider EL. Appearance of hypoxanthine guanine phosphoribosyltransferase activity as a consequence of mycoplasma contamination Nature. 256: 329-331. PMID 1143337 DOI: 10.1038/256329A0  0.398
1975 Schneider EL, Stanbridge EJ. A simple biochemical technique for the detection of mycoplasma contamination of cultured cells Methods in Cell Biology. 277-290. DOI: 10.1016/S0091-679X(08)60742-6  0.315
1974 Schneider EL, Stanbridge EJ, Epstein CJ, Golbus M, Abbo-Halbasch G, Rodgers G. Mycoplasma contamination of cultured amniotic fluid cells: Potential hazard to prenatal chromosomal diagnosis Science. 184: 477-480. PMID 4819680 DOI: 10.1126/Science.184.4135.477  0.336
1974 Tomkins GA, Stanbridge EJ, Hayflick L. Viral probes of aging in the human diploid cell strain WI-38. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 146: 385-90. PMID 4365308 DOI: 10.3181/00379727-146-38110  0.55
1973 Brautbar C, Stanbridge EJ, Pellegrino MA, Ferrone S, Reisfeld RA, Payne R, Hayflick L. Expression of HL A antigens on cultured human fibroblasts infected with mycoplasmas Journal of Immunology. 111: 1783-1789. PMID 4127300  0.503
1972 Stanbridge EJ, Perkins FT, Hayflick L. Cell tumourigenicity detected by heterotransplantation into mice immunosuppressed with anti-lymphocytic serum Progress in Immunobiological Standardization. 5: 243-251. PMID 4349827  0.48
1971 Stanbridge EJ, Hayflick L, Perkins FT. Modification of amino-acid concentrations induced by mycoplasmas in cell culture medium Nature: New Biology. 232: 242-244. PMID 5286195 DOI: 10.1038/Newbio232242A0  0.564
1969 Stanbridge E, Önen M, Perkins FT, Hayflick L. Karyological and morphological characteristics of human diploid cell strain WI-38 infected with mycoplasmas Experimental Cell Research. 57: 397-410. PMID 5347639 DOI: 10.1016/0014-4827(69)90166-9  0.585
1967 Stanbridge E, Hayflick L. Growth inhibition test for identification of Mycoplasma species utilizing dried antiserum-impregnated paper discs. Journal of Bacteriology. 93: 1392-6. PMID 5340308 DOI: 10.1128/Jb.93.4.1392-1396.1967  0.52
1967 Hayflick L, Stanbridge E. Isolation and identification of mycoplasma from human clinical materials. Annals of the New York Academy of Sciences. 143: 608-21. PMID 5233792 DOI: 10.1111/J.1749-6632.1967.Tb27705.X  0.455
1967 Stanbridge E, Hayflick L. Growth Inhibition Test for Identification of Mycoplasma Species Utilizing Dried Antiserum-Impregnated Paper Discs Journal of Bacteriology. 93: 1392-1396. DOI: 10.1128/jb.93.4.1392-1396.1967  0.45
Low-probability matches (unlikely to be authored by this person)
2005 Proescholdt MA, Mayer C, Kubitza M, Schubert T, Liao SY, Stanbridge EJ, Ivanov S, Oldfield EH, Brawanski A, Merrill MJ. Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro-Oncology. 7: 465-75. PMID 16212811 DOI: 10.1215/S1152851705000025  0.298
2003 DeSimone JN, Bengtsson U, Wang X, Lao XY, Redpath JL, Stanbridge EJ. Complexity of the mechanisms of initiation and maintenance of DNA damage-induced G2-phase arrest and subsequent G1-phase arrest: TP53-dependent and TP53-independent roles. Radiation Research. 159: 72-85. PMID 12492370 DOI: 10.1667/0033-7587(2003)159[0072:Cotmoi]2.0.Co;2  0.297
1994 Sato KY, Polakis PG, Haubruck H, Fasching CL, McCormick F, Stanbridge EJ. Analysis of the Tumor Suppressor Activity of the K-rev-1 Gene in Human Tumor Cell Lines Cancer Research. 54: 552-559. PMID 8275494  0.295
1994 Welch DR, Chen P, Miele ME, McGary CT, Bower JM, Stanbridge EJ, Weissman BE. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene. 9: 255-62. PMID 8302587  0.294
1975 Schneider EL, Stanbridge EJ. Comparison of methods for the detection of mycoplasmal contamination of cell cultures: A review In Vitro. 11: 20-34. PMID 1092606 DOI: 10.1007/Bf02615318  0.294
1988 Stanbridge EJ. Genetic analysis of human malignancy using somatic cell hybrids and monochromosome transfer Cancer Surveys. 7: 317-324. PMID 3066478  0.294
1984 Gobel UB, Stanbridge EJ. Cloned mycoplasma ribosomal RNA genes for the detection of mycoplasma contamination in tissue cultures Science. 226: 1211-1213. PMID 6505688 DOI: 10.1126/Science.6505688  0.293
2004 Atkins M, McDermott D, Regan M, Stanbridge E, Upton M, Youmans A, Febbo P, Lechpammer M, Signoretti S. Carbonic Anhydrase IX (CAIX) expression predicts for renal cell cancer (RCC) patient response and survival to IL-2 therapy Journal of Clinical Oncology. 22: 4512-4512. DOI: 10.1200/Jco.2004.22.14_Suppl.4512  0.293
1995 Jongmans W, Verhaegh GWCT, Jaspers NGJ, Oshimura M, Stanbridge EJ, Lohman PHM, Zdzienicka MZ. Studies on phenotypic complementation of ataxia-telangiectasia cells by chromosome transfer American Journal of Human Genetics. 56: 438-443. PMID 7847380  0.293
2007 Wang XQ, Stanbridge EJ, Lao X, Cai Q, Fan ST, Redpath JL. p53-dependent Chk1 phosphorylation is required for maintenance of prolonged G2 Arrest. Radiation Research. 168: 706-15. PMID 18088187 DOI: 10.1667/Rr1075.1  0.291
1990 Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA, Fusenig NE. c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Research. 50: 2840-7. PMID 2183932  0.289
2017 Lung HL, Lo PHY, Xie D, Apte SS, Cheung AKL, Cheng Y, Law EWL, Chua D, Zeng YX, Tsao SW, Stanbridge EJ, Lung ML. Erratum to: Expression of concern: Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma : ADAMTS9 Gene in Nasopharyngeal Carcinoma (International Journal of Cancer, (2008), 123, 2, (401-408), 10.1002/ijc.23528) International Journal of Cancer. 141. PMID 32872707 DOI: 10.1002/Ijc.31032  0.289
2004 Li H, Sims CE, Kaluzova M, Stanbridge EJ, Allbritton NL. A quantitative single-cell assay for protein kinase B reveals important insights into the biochemical behavior of an intracellular substrate peptide. Biochemistry. 43: 1599-608. PMID 14769036 DOI: 10.1021/Bi035597K  0.286
2009 Kaluz S, Kaluzová M, Liao SY, Lerman M, Stanbridge EJ. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? Biochimica Et Biophysica Acta. 1795: 162-72. PMID 19344680 DOI: 10.1016/J.Bbcan.2009.01.001  0.286
2006 Jankovic B, Aquino-Parsons C, Raleigh JA, Stanbridge EJ, Durand RE, Banath JP, MacPhail SH, Olive PL. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix Cytometry Part B - Clinical Cytometry. 70: 45-55. PMID 16456867 DOI: 10.1002/Cyto.B.20086  0.286
1980 Weissman B, Stanbridge EJ. Characterization of ouabain resistant, hypoxanthine phosphoribosyl transferase deficient human cells and their usefulness as a general method for the production of human cell hybrids Cytogenetics and Cell Genetics. 28: 227-239. PMID 6450667  0.285
2004 Yang LC, Tang JC, Srivastava G, Stanbridge EJ, Lung ML. Functional investigation of tumor suppressive role of chromosome 9 in esophageal squamous cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 9571. PMID 28016658 DOI: 10.1200/Jco.2004.22.14_Suppl.9571  0.284
1994 Zabarovsky ER, Kashuba VI, Pettersson B, Petrov N, Zakharyev V, Gizatullin R, Lebedeva T, Bannikov V, Pokrovskaya ES, Zabarovska VI, Allikmets R, Erlandsson R, Domninsky D, Sumegi J, Stanbridge EJ, et al. Shot-gun sequencing strategy for long-range genome mapping : a pilot study Genomics. 21: 495-500. PMID 7959725 DOI: 10.1006/Geno.1994.1307  0.284
1996 Farmer AA, Johnsen JI, Loftus TM, Smith KP, Stanbridge EJ. Isolation and characterization of the QM promoter. Nucleic Acids Research. 24: 2158-65. PMID 8668549 DOI: 10.1093/Nar/24.11.2158  0.283
1993 Zabarovsky ER, Kashuba VI, Pokrovskaya ES, Zabarovska VI, Wang JY, Berglund P, Boldog F, Stanbridge EJ, Sumegi J, Klein G. Alu-PCR approach to isolating NotI-linking clones from the 3p14-p21 region frequently deleted in renal cell carcinoma. Genomics. 16: 713-9. PMID 8325645 DOI: 10.1006/Geno.1993.1252  0.28
2004 Cho D, Signoretti S, Regan M, Ko Y, McDermott D, Lechpammer M, Polivy A, Youmans A, Stanbridge E, Atkins M. Carbonic Anyhydrase IX (CAIX) Expression Does Not Correlate with the Renal Cell Cancer (RCC) Patient Response to CCI-779 Journal of Immunotherapy. 27: S12. DOI: 10.1097/00002371-200411000-00048  0.279
1978 Stanbridge EJ, Weiss RL. Mycoplasma capping on lymphocytes Nature. 276: 583-587. PMID 723942 DOI: 10.1038/276583A0  0.278
1998 Aurelio ON, Cajot JF, Hua MLH, Khwaja Z, Stanbridge EJ. Germ-line-derived hinge domain p53 mutants have lost apoptotic but not cell cycle arrest functions Cancer Research. 58: 2190-2195. PMID 9605765  0.277
1995 Pellegata NS, Cajot JF, Stanbridge EJ. The basic carboxy-terminal domain of human p53 is dispensable for both transcriptional regulation and inhibition of tumor cell growth Oncogene. 11: 337-349. PMID 7624148  0.275
2006 Kaluz S, Kaluzová M, Stanbridge EJ. Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain. Molecular and Cellular Biology. 26: 5895-907. PMID 16847340 DOI: 10.1128/Mcb.00552-06  0.275
1992 Stanbridge EJ. Functional evidence for human tumour suppressor genes: Chromosome and molecular genetic studies Cancer Surveys. 12: 5-24. PMID 1353413  0.273
1988 McCullough JL, Weinstein GD, Ross P, Barr RJ, Stanbridge EJ. Identification of differentiation-specific antigens in psoriatic versus normal skin using monoclonal antibodies International Journal of Dermatology. 27: 628-632. PMID 2466008 DOI: 10.1111/J.1365-4362.1988.Tb02420.X  0.273
1996 Opavský R, Pastoreková S, Zelník V, Gibadulinová A, Stanbridge EJ, Závada J, Kettmann R, Pastorek J. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships Genomics. 33: 480-487. PMID 8661007 DOI: 10.1006/Geno.1996.0223  0.272
2002 Chan AS, Lai FP, Lo RK, Voyno-Yasenetskaya TA, Stanbridge EJ, Wong YH. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cellular Signalling. 14: 249-57. PMID 11812653 DOI: 10.1016/S0898-6568(01)00240-6  0.27
1994 Farmer AA, Loftus TM, Mills AA, Sato KY, Neill JD, Tron T, Yang M, Trumpower BL, Stanbridge EJ. Extreme evolutionary conservation of QM, a novel c-Jun associated transcription factor. Human Molecular Genetics. 3: 723-8. PMID 8081358 DOI: 10.1093/Hmg/3.5.723  0.27
1989 Geiser AG, Anderson MJ, Stanbridge EJ. Suppression of tumorigenicity in human cell hybrids derived from cell lines expressing different activated ras oncogenes. Cancer Research. 49: 1572-7. PMID 2647289  0.269
2008 Kaluz S, Kaluzová M, Stanbridge EJ. Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element. Clinica Chimica Acta; International Journal of Clinical Chemistry. 395: 6-13. PMID 18505681 DOI: 10.1016/J.Cca.2008.05.002  0.269
1981 Stanbridge EJ, Ceredig R. Growth-Regulatory Control of Human Cell Hybrids in Nude Mice Cancer Research. 41: 573-580. PMID 7448804  0.268
2000 Liao SY, Stanbridge EJ. Expression of MN/CA9 protein in papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia Cancer. 88: 1108-1121. PMID 10699902 DOI: 10.1002/(Sici)1097-0142(20000301)88:5<1108::Aid-Cncr23>3.0.Co;2-D  0.267
1990 Newstein M, Stanbridge EJ, Casey G, Shank PR. Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells Journal of Virology. 64: 4565-4567. PMID 2200890  0.266
1989 Saxon PJ, Schultz RA, Stanbridge EJ, Friedberg EC. Human chromosome 15 confers partial complementation of phenotypes to xeroderma pigmentosum group F cells American Journal of Human Genetics. 44: 474-485. PMID 2929593  0.266
2001 Kaluzová M, Pastoreková S, Svastová E, Pastorek J, Stanbridge EJ, Kaluz S. Characterization of the MN/CA 9 promoter proximal region: A role for specificity protein (SP) and activator protein 1 (AP1) factors Biochemical Journal. 359: 669-677. PMID 11672442 DOI: 10.1042/0264-6021:3590669  0.266
1991 Casey G, Lo-Hsueh M, Lopez ME, Vogelstein B, Stanbridge EJ. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene Oncogene. 6: 1791-1797. PMID 1923504  0.265
1982 Doersen CJ, Stanbridge EJ. Erythromycin inhibition of cell proliferation and in vitro mitochondrial protein synthesis in human HeLa cells is pH dependent Bba - Gene Structure and Expression. 698: 62-69. PMID 7115721 DOI: 10.1016/0167-4781(82)90185-3  0.263
2012 Watanabe M, Abe N, Oshikiri Y, Stanbridge EJ, Kitagawa T. Selective growth inhibition by glycogen synthase kinase-3 inhibitors in tumorigenic HeLa hybrid cells is mediated through NF-κB-dependent GLUT3 expression Oncogenesis. 1. DOI: 10.1038/oncsis.2012.21  0.263
2007 Cho D, Signoretti S, Dabora S, Regan M, Seeley A, Mariotti M, Youmans A, Polivy A, Mandato L, McDermott D, Stanbridge E, Atkins M. Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma Clinical Cancer Updates. 1: 85-91. DOI: 10.3816/Ccu.2007.N.014  0.262
1983 Weissman BE, Stanbridge EJ. Complexity of control of tumorigenic expression in intraspecies hybrids of human SV40-transformed fibroblasts and normal human fibroblast cell lines Cytogenetics and Cell Genetics. 35: 263-268. PMID 6311488  0.262
1974 Schneider EL, Stanbridge EJ, Epstein CJ. Incorporation of 3H-uridine and 3H-uracil into RNA. A simple technique for the detection of mycoplasma contamination of cultured cells Experimental Cell Research. 84: 311-318. PMID 4817725 DOI: 10.1016/0014-4827(74)90411-X  0.259
1985 Redpath JL, Sun C, Colman M, Stanbridge EJ. Radiobiological studies of human hybrid cells (skin fibroblasts × hela) and their tumourigenic segregants International Journal of Radiation Biology. 48: 479-483. PMID 3876302 DOI: 10.1080/09553008514551541  0.256
1981 Der CJ, Ash JF, Stanbridge EJ. Cytoskeletal and transmembrane interactions in the expression of tumourigenicity in human cell hybrids Journal of Cell Science. 151-166. PMID 7037799  0.253
2011 Liao SY, Rodgers WH, Kauderer J, Bonfiglio TA, Darcy KM, Carter R, Levine L, Spirtos NM, Susumu N, Fujiwara K, Walker JL, Hatae M, Stanbridge EJ. Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study. British Journal of Cancer. 104: 353-60. PMID 21157448 DOI: 10.1038/Sj.Bjc.6606049  0.252
2005 Atkins M, Regan M, McDermott D, Mier J, Stanbridge E, Youmans A, Febbo P, Upton M, Lechpammer M, Signoretti S. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3714-21. PMID 15897568 DOI: 10.1158/1078-0432.Ccr-04-2019  0.251
1981 Peehl DM, Stanbridge EJ. Anchorage-independent growth of normal human fibroblasts Proceedings of the National Academy of Sciences of the United States of America. 78: 3053-3057. PMID 6942414  0.25
1976 Reff ME, Stanbridge EJ. Conformational differences in bacterial ribosomal RNAs in non-denaturing conditions Nature. 260: 724-726. PMID 817211 DOI: 10.1038/260724A0  0.245
2013 Liao SY, Rodgers WH, Kauderer J, Darcy KM, Carter R, Susumu N, Nagao S, Walker JL, Hatae M, Stanbridge EJ. Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study. British Journal of Cancer. 108: 613-20. PMID 23299542 DOI: 10.1038/Bjc.2012.578  0.245
2008 Kaluz S, Kaluzová M, Stanbridge EJ. Does inhibition of degradation of hypoxia-inducible factor (HIF) alpha always lead to activation of HIF? Lessons learnt from the effect of proteasomal inhibition on HIF activity. Journal of Cellular Biochemistry. 104: 536-44. PMID 18059036 DOI: 10.1002/Jcb.21644  0.244
1994 Perucho M, Casares S, Ionov Y, Malkhosyan S, Shibata D, Stanbridge E. Somatic genomic instability at microsatellites: A persistent and early event in cancer of the recessive mutator phenotype Pathophysiology. 1: 114. DOI: 10.1016/0928-4680(94)90251-8  0.243
2002 Kaluz S, Kaluzová M, Chrastina A, Olive PL, Pastoreková S, Pastorek J, Lerman MI, Stanbridge EJ. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase. Cancer Research. 62: 4469-77. PMID 12154057  0.237
1985 Sun C, Redpath JL, Colman M, Stanbridge EJ. Repair of potentially lethal radiation damage in confluent and non-confluent cultures of human hybrid cells International Journal of Radiation Biology. 49: 395-402. PMID 3485588 DOI: 10.1080/09553008514552621  0.236
2008 Kaluz S, Kaluzová M, Stanbridge EJ. Rational design of minimal hypoxia-inducible enhancers. Biochemical and Biophysical Research Communications. 370: 613-8. PMID 18402769 DOI: 10.1016/J.Bbrc.2008.03.147  0.235
2004 Soughayer JS, Wang Y, Li H, Cheung SH, Rossi FM, Stanbridge EJ, Sims CE, Allbritton NL. Characterization of TAT-mediated transport of detachable kinase substrates. Biochemistry. 43: 8528-40. PMID 15222764 DOI: 10.1021/Bi036296D  0.235
2009 Liao SY, Rodgers WH, Kauderer J, Bonfiglio TA, Walker JL, Darcy KM, Carter R, Hatae M, Levine L, Spirtos NM, Stanbridge EJ. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States. International Journal of Cancer. Journal International Du Cancer. 125: 2434-40. PMID 19670419 DOI: 10.1002/Ijc.24615  0.234
2015 Ch'ng WC, Abd-Aziz N, Ong MH, Stanbridge EJ, Shafee N. Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway. Cellular Oncology (Dordrecht). 38: 279-88. PMID 25930675 DOI: 10.1007/s13402-015-0229-5  0.233
1987 Gobel UB, Geiser A, Stanbridge EJ. Oligonucleotide probes complementary to variable regions of ribosomal RNA discriminate between Mycoplasma species Journal of General Microbiology. 133: 1969-1974. PMID 2444670 DOI: 10.1099/00221287-133-7-1969  0.233
1969 Stanbridge EJ, Perkins FT. Tumour nodule formation as an in vivo measure of the suppression of cellular immune response by antilymphocytic serum Nature. 221: 80-81. PMID 4882052 DOI: 10.1038/221080A0  0.232
1985 Weissman BE, Mark CS, Benedict WF, Stanbridge EJ. Expression of the N-ras oncogene in tumorigenic and non-tumorigenic HT 1080 fibrosarcoma X normal human fibroblast hybrid cells Progress in Clinical and Biological Research. 175: 141-149. PMID 3887427  0.231
1975 Stanbridge EJ, Boulger LR, Franks CR, Garrett JA, Reeson DE, Bishop D, Perkins FT. Optimal Conditions for the Growth of Malignant Human and Animal Cell Populations in Immunosuppressed Mice Cancer Research. 35: 2203-2212. PMID 1080073  0.231
2012 Liew SY, Stanbridge EJ, Yusoff K, Shafee N. Hypoxia affects cellular responses to plant extracts. Journal of Ethnopharmacology. 144: 453-6. PMID 23022321 DOI: 10.1016/J.Jep.2012.09.024  0.231
1996 Poulos NE, Farmer AA, Chan KWK, Stanbridge EJ. Design of a novel bicistronic expression vector with demonstration of a p16INK4-induced G1-S block Cancer Research. 56: 1719-1723. PMID 8620481  0.23
2008 Kaluz S, Kaluzová M, Stanbridge EJ. Comment on the role of FIH in the inhibitory effect of bortezomib on hypoxia-inducible factor-1. Blood. 111: 5258-9; author reply. PMID 18467614 DOI: 10.1182/Blood-2008-02-140079  0.229
2011 Ch'ng WC, Stanbridge EJ, Ong KC, Wong KT, Yusoff K, Shafee N. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment. Journal of Medical Virology. 83: 1783-91. PMID 21837796 DOI: 10.1002/Jmv.22198  0.229
2012 Carter RL, Kang L, Darcy KM, Kauderer J, Liao SY, Rodgers WH, Walker JL, Lankes HA, Dunn ST, Stanbridge EJ. A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study. Cancer Causes & Control : Ccc. 23: 2013-21. PMID 23073789 DOI: 10.1007/S10552-012-0081-0  0.227
1993 Stanbridge EJ. From the cancer cell biology point of view Advances in Experimental Medicine and Biology. 330: 307-314. PMID 8368139 DOI: 10.1007/978-1-4615-2926-2_21  0.225
1995 Perucho M, Peinado MA, Ionov Y, Casares S, Malkhosyan S, Stanbridge E. Defects in replication fidelity of simple repeated sequences reveal a new mutator mechanism for oncogenesis. Cold Spring Harbor Symposia On Quantitative Biology. 59: 339-48. PMID 7587086 DOI: 10.1101/Sqb.1994.059.01.038  0.221
2012 Ch'ng WC, Stanbridge EJ, Wong KT, Ong KC, Yusoff K, Shafee N. Immunization with recombinant enterovirus 71 viral capsid protein 1 fragment stimulated antibody responses in hamsters. Virology Journal. 9: 155. PMID 22877087 DOI: 10.1186/1743-422X-9-155  0.217
2003 Kuzmin I, Liu L, Dammann R, Geil L, Stanbridge EJ, Wilczynski SP, Lerman MI, Pfeifer GP. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Research. 63: 1888-93. PMID 12702579  0.216
1985 Bicknell DC, Sutherland DR, Stanbridge EJ, Greaves MF. Monoclonal antibodies specific for a tumor-associated membrane phosphoprotein in human cell hybrids Hybridoma. 4: 143-152. PMID 2408990  0.215
1985 Stanbridge EJ. Case for genetic regulatory elements that control tumorigenic expression in human hybrid cells Carcinogenesis; a Comprehensive Survey. 9: 81-85. PMID 4053089  0.215
1986 Stanbridge EJ, Araujo D, Ross P, Butler G, McCullough J, Wilkinson J. A Novel Approach for Obtaining and Identifying Monoclonal Antibodies That React with Differentiation-specific Antigens Using Human Hybrid Cells Cancer Research. 46: 4759-4764. PMID 3731123  0.215
1981 Stanbridge EJ, Bretzius KA, Good RF. Mycoplasma-lymphocyte interactions: IR gene control of mitogenesis and a paradoxical interaction with Thy-1 bearing cells Israel Journal of Medical Sciences. 17: 628-632. PMID 6793536  0.214
2000 Bernhard EJ, Stanbridge EJ, Gupta S, Gupta AK, Soto D, Bakanauskas VJ, Cerniglia GJ, Muschel RJ, McKenna WG. Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines. Cancer Research. 60: 6597-600. PMID 11118040  0.213
2002 Guo X, Lui WO, Qian CN, Chen JD, Gray SG, Rhodes D, Haab B, Stanbridge E, Wang H, Hong MH, Min HQ, Larsson C, Teh BT. Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses. International Journal of Oncology. 21: 1197-204. PMID 12429968  0.211
1977 Reff ME, Stanbridge EJ, Schneider EL. Phylogenetic relationships between mycoplasmas and other procaryotes based upon the electrophoretic behavior of their ribosomal ribonucleic acids International Journal of Systematic Bacteriology. 27: 185-193. DOI: 10.1099/00207713-27-3-185  0.21
2010 Liao SY, Darcy KM, Randall LM, Tian C, Monk BJ, Burger RA, Fruehauf JP, Peters WA, Stock RJ, Stanbridge EJ. Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study. Gynecologic Oncology. 116: 452-8. PMID 19913895 DOI: 10.1016/J.Ygyno.2009.10.062  0.21
1988 Stanbridge EJ. A brief review of the evidence of the genetic regulation of tumorigenic expression in somatic cell hybrids Iarc Scientific Publications. 23-31. PMID 3069730  0.209
1989 Redpath JL, Sun C, Stanbridge EJ. Satellite colony formation: a potential problem in the quantitative assay for neoplastic transformation of human cell hybrids (HeLa x skin fibroblasts) Radiation Research. 117: 356-358. PMID 2922479  0.199
1991 Barrett JC, Afshari CA, Annab LA, Burkhart BA, Boyd JA, Owen RD, Futreal PA, Richter KH, Moses HL, Lavker RM, Miller S, Sun T-, Stingl G, Bianchi AB, Navone NM, ... ... Stanbridge EJ, et al. Supplement II: Abstracts of the international symposium on Skin Carcinogenesis in man and in experimental models. Heidelberg, 29–31 October 1991 (pp S61–S88) Journal of Cancer Research and Clinical Oncology. 117: S61-S83. DOI: 10.1007/Bf01613300  0.188
1990 Friedberg EC, Henning K, Lambert C, Saxon PJ, Schultz RA, Sekhon GS, Stanbridge EJ. Microcell-mediated chromosome transfer: a strategy for studying the genetics and molecular pathology of human hereditary diseases with abnormal responses to DNA damage. Basic Life Sciences. 52: 257-67. PMID 2183771 DOI: 10.1007/978-1-4615-9561-8_21  0.185
1988 Youngman S, Shaw DJ, Gusella JF, Macdonald M, Stanbridge EJ, Wasmuth J, Harper PS. A DNA probe, D5 [D4S90] mapping to human chromosome 4p16.3 Nucleic Acids Research. 16: 1648. PMID 2894638 DOI: 10.1093/Nar/16.4.1648  0.185
1983 Butler GH, Stanbridge EJ. Infection of mouse lymphoblastoid cell lines with Mycoplasma hyorhinis: Complex nature of mycoplasma-host cell interactions Infection and Immunity. 42: 1136-1143. PMID 6642662  0.184
1997 Nguyen-Yue YH, Loftus TM, Torok T, Bryant P, Stanbridge EJ. The isolation, localization and characterization of the QM homolog in drosophila melanogaster Mitochondrial Dna. 7: 337-347. PMID 9524813 DOI: 10.3109/10425179709034053  0.18
2005 Ivanova A, Liao SY, Lerman MI, Ivanov S, Stanbridge EJ. STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker. Journal of Medical Genetics. 42: 565-76. PMID 15994878 DOI: 10.1136/jmg.2004.029835  0.178
1989 Geiser AG, Stanbridge EJ. A review of the evidence for tumor suppressor genes Critical Reviews in Oncogenesis. 1: 261-276. PMID 2488133  0.174
1982 Stanbridge E. Mycoplasmal Immunity and Immunopathology: Summary Clinical Infectious Diseases. 4: S227-S228. DOI: 10.1093/Clinids/4.Supplement_1.S227  0.171
1989 Mendonca MS, Boukamp P, Stanbridge EJ, Redpath JL. Radiosensitivity of human keratinocytes: Influence of activated c-h-ras oncogene expression and tumorigenicity International Journal of Radiation Biology. 56: 847-847. DOI: 10.1080/09553008914552211  0.17
1996 Liao SY, Stanbridge EJ. Expression of the MN antigen in cervical Papanicolaou smears is an early diagnostic biomarker of cervical dysplasia Cancer Epidemiology Biomarkers and Prevention. 5: 549-557. PMID 8827360  0.169
1979 Doersen CJ, Stanbridge EJ. Cytoplasmic inheritance of erythromycin resistance in human cells Proceedings of the National Academy of Sciences of the United States of America. 76: 4549-4553. PMID 291986  0.163
1971 Stanbridge E. Mycoplasmas and cell cultures. Bacteriological Reviews. 35: 206-227. DOI: 10.1128/mmbr.35.2.206-227.1971  0.163
1989 Stanbridge EJ. The reemergence of tumor suppression Cancer Cells. 1: 31-32. PMID 2701360  0.159
1979 Doersen CJ, Stanbridge EJ. Cytoplasmic inheritance of erythromycin resistance in HeLa cells Journal of Supramolecular and Cellular Biochemistry. 384.  0.143
1976 Stanbridge EJ, Schneider EL. A simple biochemical method for the detection of mycoplasmas and other microbial contaminants of cell cultures Tissue Culture Association Manual. 2: 371-374. DOI: 10.1007/BF00921623  0.14
1981 Stanbridge EJ. Mycoplasma detection- An obligation to scientific accuracy Israel Journal of Medical Sciences. 17: 563-568. PMID 7026495  0.139
2003 Kaluz S, Kaluzová M, Stanbridge EJ. Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer. Cancer Research. 63: 917-22. PMID 12615703  0.135
1976 Stanbridge EJ, Schneider EL. The need for non-cultural methods for the detection of mycoplasma contaminants Developments in Biological Standardization. 37: 191-200. PMID 1031685  0.125
1987 Göbel U, Maas R, Haun G, Vinga-Martins C, Stanbridge EJ. Synthetic oligonucleotide probes complementary to rRNA for group- and species-specific detection of mycoplasmas Israel Journal of Medical Sciences. 23: 742-746. PMID 2889700  0.121
2004 Bui MH, Visapaa H, Seligson D, Kim H, Han KR, Huang Y, Horvath S, Stanbridge EJ, Palotie A, Figlin RA, Belldegrun AS. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma. The Journal of Urology. 171: 2461-6. PMID 15126876  0.108
2003 Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 802-11. PMID 12576453  0.105
1976 Stanbridge EJ. A reevaluation of the role of mycoplasmas in human disease Annual Review of Microbiology. 30: 169-187. PMID 791065  0.102
2005 Stone JE, Parker R, Gilks CB, Stanbridge EJ, Liao SY, Aquino-Parsons C. Intratumoral oxygenation of invasive squamous cell carcimoma of the vulva is not correlated with regional lymph node metastasis European Journal of Gynaecological Oncology. 26: 31-35. PMID 15754996  0.096
1991 Butler GH, Kotani H, Kong L, Frick M, Evancho S, Stanbridge EJ, McGarrity GJ. Identification and characterization of proteinase K-resistant proteins in members of the class Mollicutes Infection and Immunity. 59: 1037-1042. PMID 1997407  0.094
2003 Liao SY, Ivanov S, Ivanova A, Ghosh S, Cote MA, Keefe K, Coca-Prados M, Stanbridge EJ, Lerman MI. Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma. Journal of Medical Genetics. 40: 257-61. PMID 12676895 DOI: 10.1136/jmg.40.4.257  0.091
2005 Wang XQ, Luk JM, Leung PP, Wong BW, Stanbridge EJ, Fan ST. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 483-9. PMID 15701831  0.09
1984 Butler GH, Gobel U, Stanbridge EJ. Blast transformation of mouse splenic B-lymphocytes with extracts of Mycoplasma hyorhinis Israel Journal of Medical Sciences. 20: 891-894. PMID 6334671  0.084
1984 Gobel U, Butler GH, Stanbridge EJ. Comparative analysis of mycoplasma ribosomal RNA operons Israel Journal of Medical Sciences. 20: 762-764. PMID 6096302  0.076
1991 Lehmer RR, Andrews BS, Robertson JA, Stanbridge EJ, de la Maza L, Friou GJ. Clinical and biological characteristics of Ureaplasma urealyticum induced polyarthritis in a patient with common variable hypogammaglobulinaemia. Annals of the Rheumatic Diseases. 50: 574-6. PMID 1888200 DOI: 10.1136/ard.50.8.574  0.076
1997 Brewer CA, Liao SY, Wilczynski SP, Pastorekova S, Pastorek J, Zavada J, Kurosaki T, Manetta A, Berman ML, DiSaia PJ, Stanbridge EJ. A Study of Biomarkers and Cervical Carcinoma and Clinical Correlation of Novel Biomarker MN Journal of Lower Genital Tract Disease. 1: 160. DOI: 10.1097/00128360-199707000-00012  0.051
1977 Mills LB, Stanbridge EJ, Sedwick WD, Korn D. Purification and partial characterization of the principal deoxyribonucleic acid polymerase from Mycoplasmatales Journal of Bacteriology. 132: 641-649. PMID 914780  0.049
1977 Stanbridge EJ, Perkins FT. Tumourigenicity testing in immunosuppressed mice: advantages and disadvantages Developments in Biological Standardization. 211-217. PMID 1031686  0.033
Hide low-probability matches.